These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 27921154)

  • 1. Peripheral Stent Thrombosis Leading to Acute Limb Ischemia and Major Amputation: Incidence and Risk Factors in the Aortoiliac and Femoropopliteal Arteries.
    Katsanos K; Al-Lamki SA; Parthipun A; Spiliopoulos S; Patel SD; Paraskevopoulos I; Zayed H; Diamantopoulos A
    Cardiovasc Intervent Radiol; 2017 Mar; 40(3):351-359. PubMed ID: 27921154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Real-World Experience With the Supera Interwoven Nitinol Stent in Femoropopliteal Arteries: Midterm Patency Results and Failure Analysis.
    Myint M; Schouten O; Bourke V; Thomas SD; Lennox AF; Varcoe RL
    J Endovasc Ther; 2016 Jun; 23(3):433-41. PubMed ID: 27004494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity Score Analysis Comparing Clinical Outcomes of Drug-Eluting vs Bare Nitinol Stents in Femoropopliteal Lesions.
    Soga Y; Takahara M; Iida O; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Ando K
    J Endovasc Ther; 2016 Feb; 23(1):33-9. PubMed ID: 26763256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Outcomes of Supera Interwoven Nitinol vs Bare Nitinol Stents for the Treatment of Femoropopliteal Disease: Insights From the XLPAD Registry.
    Armstrong EJ; Jeon-Slaughter H; Kahlon RS; Niazi KA; Shammas NW; Banerjee S
    J Endovasc Ther; 2020 Feb; 27(1):60-65. PubMed ID: 31686573
    [No Abstract]   [Full Text] [Related]  

  • 5. Covered vs Uncovered Stents for Aortoiliac and Femoropopliteal Arterial Disease: A Systematic Review and Meta-analysis.
    Hajibandeh S; Hajibandeh S; Antoniou SA; Torella F; Antoniou GA
    J Endovasc Ther; 2016 Jun; 23(3):442-52. PubMed ID: 27099281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of endovascular therapy for femoropopliteal disease with the Supera stent.
    Montero-Baker M; Ziomek GJ; Leon L; Gonzales A; Dieter RS; Gadd CL; Pacanowski JP
    J Vasc Surg; 2016 Oct; 64(4):1002-8. PubMed ID: 27444365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of femoropopliteal stenting. Results of a prospective study.
    Schönefeld E; Torsello G; Osada N; Herten M; Bisdas T; Donas KP
    J Cardiovasc Surg (Torino); 2013 Oct; 54(5):617-23. PubMed ID: 24002391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bare nitinol stent enabled recanalization of long-segment, chronic total occlusion of superficial femoral and adjacent proximal popliteal artery in diabetic patients presenting with critical limb ischemia.
    Taneja M; Tay KH; Dewan A; Sebastian MG; Pasupathy S; Lin SE; Teo T; Lo R; Tan SG; Irani FG; Tan BS
    Cardiovasc Revasc Med; 2010; 11(4):232-5. PubMed ID: 20934655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atheromatous occlusive lesions of the popliteal artery treated with stent grafts: predictive factors of midterm patency.
    Peidro J; Boufi M; Loundou Dieudonné A; Hartung O; Dona B; Vernet F; Alimi Y
    Ann Vasc Surg; 2015; 29(4):708-15. PubMed ID: 25595105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
    Chan YC; Cheng SW; Cheung GC
    J Vasc Surg; 2015 Nov; 62(5):1201-9. PubMed ID: 26169015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
    Tran K; Ullery BW; Kret MR; Lee JT
    Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis).
    Dippel EJ; Makam P; Kovach R; George JC; Patlola R; Metzger DC; Mena-Hurtado C; Beasley R; Soukas P; Colon-Hernandez PJ; Stark MA; Walker C;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):92-101. PubMed ID: 25499305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.
    Rocha-Singh KJ; Beckman JA; Ansel G; Lyden SP; Schneider P; Mehta M; Dake M; Mullin CM; Jaff MR;
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1250-1256. PubMed ID: 28303688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A midterm analysis of patients who received femoropopliteal helical interwoven nitinol stents.
    Chan YC; Cheng SW; Cheung GC
    J Vasc Surg; 2020 Jun; 71(6):2048-2055. PubMed ID: 32081479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, clinical outcome, and fracture rate of femoropopliteal stenting using a 4F compatible delivery system.
    Sarkadi H; Bérczi V; Kollár A; Kiss D; Jakabfi P; Végh EM; Nemes B; Merkely B; Hüttl K; Dósa E
    Eur J Vasc Endovasc Surg; 2015 Feb; 49(2):199-204. PubMed ID: 25579877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
    Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
    J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis.
    Sabeti S; Schillinger M; Amighi J; Sherif C; Mlekusch W; Ahmadi R; Minar E
    Radiology; 2004 Aug; 232(2):516-21. PubMed ID: 15286322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with failed femoropopliteal covered stents are more likely to present with acute limb ischemia than those with failed femoropopliteal bare metal stents.
    DeCarlo C; Boitano LT; Latz CA; Png CYM; Lee S; Dua A; Patel V; Schwartz SI
    J Vasc Surg; 2021 Jul; 74(1):161-169.e1. PubMed ID: 33548436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary stenting for TASC C and D femoropopliteal lesions: one-year results from a multicentric trial on 203 patients.
    Brouillet J; Deloose K; Goueffic Y; Poirier M; Midy D; Caradu C; Ducasse E
    J Cardiovasc Surg (Torino); 2018 Jun; 59(3):392-404. PubMed ID: 27272981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results from a multicenter registry of heparin-bonded expanded polytetrafluoroethylene graft for above-the-knee femoropopliteal bypass.
    Piffaretti G; Dorigo W; Castelli P; Pratesi C; Pulli R;
    J Vasc Surg; 2018 May; 67(5):1463-1471.e1. PubMed ID: 29175037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.